{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:08:28Z","timestamp":1723248508337},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>The first indwelling pleural catheter (IPC) received Federal Drug Administration approval in 1997, nearly 40 years after John Chambers first described instillation of talc into the pleural space for palliation of malignant pleural effusions. Since then IPCs have revolutionized the management of malignant pleural effusions, providing an effective means of controlling dyspnea in the end stages of life without the pain and prolonged hospital stays long associated with chemical sclerosing agents. While palliation of symptoms is the primary purpose of IPCs, development of pleurodesis in the outpatient setting is often an important secondary goal. Historically, decisions regarding IPC drainage frequency have been largely arbitrary and only recently has the evidence started to emerge regarding the effects of specific drainage strategies on both symptom control and pleurodesis development. This focused clinical review explores the current literature regarding IPC drainage strategies as well as novel methods designed to improve the efficacy of IPCs in a thorough and systematic manner. In addition, this review provides an in-depth analysis and synthesis of the data focusing on key considerations needed to develop patient-centered and cost-effective strategies for the use of IPCs in malignancy.<\/jats:p>","DOI":"10.1097\/lbr.0000000000000751","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T20:05:21Z","timestamp":1613073921000},"page":"160-167","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pleural Drainage Strategy After IPC Placement"],"prefix":"10.1097","volume":"28","author":[{"given":"Christopher R.","family":"Gilbert","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell J.","family":"Miller","sequence":"additional","affiliation":[{"name":"Pulmonary and Critical Care Medicine, Naval Medical Center San Diego, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"R1-20240809","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An Official ATS\/STS\/STR Clinical Practice Guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20240809","first-page":"1800349","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"R3-20240809","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.chest.2020.05.594","article-title":"Management of indwelling tunneled pleural catheters: a modified Delphi consensus statement","volume":"158","author":"Gilbert","year":"2020","journal-title":"Chest"},{"key":"R4-20240809","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/LBR.0000000000000707","article-title":"AABIP evidence-informed guidelines and expert panel report for the management of indwelling pleural catheters","volume":"27","author":"Miller","year":"2020","journal-title":"J Bronchology Interv Pulmonol"},{"key":"R5-20240809"},{"key":"R8-20240809","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"key":"R9-20240809","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1378\/chest.129.2.362","article-title":"Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion","volume":"129","author":"Tremblay","year":"2006","journal-title":"Chest"},{"key":"R10-20240809","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"R11-20240809","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP Trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20240809","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R13-20240809","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"key":"R14-20240809","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1378\/chest.118.3.808","article-title":"Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits","volume":"118","author":"Vargas","year":"2000","journal-title":"Chest"},{"key":"R15-20240809","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1378\/chest.122.6.2122","article-title":"Lung damage in experimental pleurodesis induced by silver nitrate or talc: 1-year follow-up","volume":"122","author":"Vargas","year":"2002","journal-title":"Chest"},{"key":"R16-20240809","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1440-1843.2009.01588.x","article-title":"Low doses of silver nitrate induce pleurodesis with a limited systemic response","volume":"14","author":"Marchi","year":"2009","journal-title":"Respirology"},{"key":"R17-20240809","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1378\/chest.119.5.1516","article-title":"Experimental pleurodesis in rabbits induced by silver nitrate or talc: 1-year follow-up","volume":"119","author":"Vargas","year":"2001","journal-title":"Chest"},{"key":"R18-20240809","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1440-1843.2011.02007.x","article-title":"Effect of repeated administration of low-dose silver nitrate for pleurodesis in a rabbit model","volume":"16","author":"Tremblay","year":"2011","journal-title":"Respirology"},{"key":"R19-20240809","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1378\/chest.128.2.684","article-title":"Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions","volume":"128","author":"Paschoalini Mda","year":"2005","journal-title":"Chest"},{"key":"R20-20240809","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/01902148.2012.731715","article-title":"Use of a drug eluting pleural catheter for pleurodesis","volume":"38","author":"Tremblay","year":"2012","journal-title":"Exp Lung Res"},{"key":"R21-20240809","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/01902148.2017.1384865","article-title":"Local and systemic effects of a silver nitrate coated indwelling pleural catheter in an animal model of pleurodesis","volume":"43","author":"Tremblay","year":"2017","journal-title":"Exp Lung Res"},{"key":"R22-20240809","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/rccm.201701-0097LE","article-title":"A novel drug-eluting indwelling pleural catheter for the management of malignant effusions","volume":"197","author":"Bhatnagar","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20240809","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.201705-0956LE","article-title":"The impact of the ASAP trial: maybe we shouldn\u2019t act so quickly","volume":"197","author":"Gilbert","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20240809","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/rccm.201706-1190LE","article-title":"Reply to Gilbert et al: the impact of the ASAP trial: maybe we shouldn\u2019t act so quickly","volume":"197","author":"Wahidi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-20240809","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.14-3119","article-title":"The use of indwelling tunneled pleural catheters for recurrent pleural effusions in patients with hematologic malignancies: a multicenter study","volume":"148","author":"Gilbert","year":"2015","journal-title":"Chest"},{"key":"R27-20240809","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","article-title":"US hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample","volume":"151","author":"Taghizadeh","year":"2017","journal-title":"Chest"},{"key":"R28-20240809","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1378\/chest.13-2481","article-title":"Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion","volume":"146","author":"Penz","year":"2014","journal-title":"Chest"},{"key":"R29-20240809","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/resp.12962","article-title":"Cost\u2010effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion","volume":"22","author":"Olfert","year":"2017","journal-title":"Respirology"},{"key":"R30-20240809","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1513\/AnnalsATS.201908-615OC","article-title":"Indwelling pleural catheter drainage strategy for malignant effusion: a cost-effectiveness analysis","volume":"17","author":"Shafiq","year":"2020","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:20:58Z","timestamp":1723216858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000751"}},"subtitle":["A Focused Clinical Review"],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000000751","relation":{},"ISSN":["1944-6586"],"issn-type":[{"type":"print","value":"1944-6586"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"2020-09-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}